title: Association between polymorphisms in DNA repair genes and survival of non-smoking female patients with lung adenocarcinoma.
abstract: BACKGROUND
  Excision repair cross-complementing group 1 (ERCC1) and group 2 (ERCC2), and X-ray repair cross-complementing group 1 (XRCC1) proteins play important roles in the repair of DNA damage and adducts. Single nucleotide polymorphisms (SNPs) of DNA repair genes are suspected to influence treatment effect and survival of cancer patients. This study aimed to investigate the relationship between polymorphisms in ERCC2, ERCC1 and XRCC1 genes and survival of non-smoking female patients with lung adenocarcinoma.
  
  
  METHODS
  We used polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method to evaluate SNPs in ERCC2, ERCC1 and XRCC1 genes among 257 patients.
  
  
  RESULTS
  The overall median survival time (MST) was 13.07 months. Increasing numbers of either ERCC1 118 or XRCC1 399 variant alleles were associated with shorter survival of non-smoking female lung adenocarcinoma patients (Log-rank P < 0.001). The adjusted hazard ratios (HRs) for individuals with CT or TT genotype at ERCC1 Asn118Asn were 1.48 and 2.67 compared with those with CC genotype. For polymorphism of XRCC1 399, the HRs were 1.28 and 2.68 for GA and AA genotype. When variant alleles across both polymorphisms were combined to analysis, the increasing number of variant alleles was associated with decreasing overall survival. Using the stepwise Cox regression analysis, we found that the polymorphisms in ERCC1 and XRCC1, tumor stage and chemotherapy or radiotherapy status independently predicted overall survival of non-smoking female patients with lung adenocarcinoma.
  
  
  CONCLUSIONS
  Genetic polymorphisms in ERCC1 and XRCC1 genes might be prognostic factors in non-smoking female patients with lung adenocarcinoma.
authors.affiliation: Department of Epidemiology, School of Public Health, China Medical University, Shenyang 110001, PR China. zhyin@mail.cmu.edu.cn
authors.forename: Zhihua
authors.initials: Z
authors.lastname: Yin
authors.forename: Baosen
authors.initials: B
authors.lastname: Zhou
authors.forename: Qincheng
authors.initials: Q
authors.lastname: He
authors.forename: Mingchuan
authors.initials: M
authors.lastname: Li
authors.forename: Peng
authors.initials: P
authors.lastname: Guan
authors.forename: Xuelian
authors.initials: X
authors.lastname: Li
authors.forename: Zeshi
authors.initials: Z
authors.lastname: Cui
authors.forename: Xiaoxia
authors.initials: X
authors.lastname: Xue
authors.forename: Meng
authors.initials: M
authors.lastname: Su
authors.forename: Rui
authors.initials: R
authors.lastname: Ma
authors.forename: Weijun
authors.initials: W
authors.lastname: Bai
authors.forename: Shuyue
authors.initials: S
authors.lastname: Xia
authors.forename: Yanduo
authors.initials: Y
authors.lastname: Jiang
authors.forename: Shun
authors.initials: S
authors.lastname: Xu
authors.forename: Yi
authors.initials: Y
authors.lastname: Lv
authors.forename: Xun
authors.initials: X
authors.lastname: Li
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis / Q000235:genetics* / Q000401:mortality*; D000293:Adolescent; D000328:Adult; D000368:Aged; D004260:DNA Repair / Q000235:genetics*; D004268:DNA-Binding Proteins / Q000235:genetics; D004720:Endonucleases / Q000235:genetics; D005260:Female; D005500:Follow-Up Studies; D008040:Genetic Linkage; D005838:Genotype; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000401:mortality*; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide; D011379:Prognosis; D012907:Smoking; D016019:Survival Analysis; D000076105:X-ray Repair Cross Complementing Protein 1; D055815:Young Adult
chemical_list: D004268:DNA-Binding Proteins; D000076105:X-ray Repair Cross Complementing Protein 1; C000619371:XRCC1 protein, human; C071447:ERCC1 protein, human; D004720:Endonucleases